From page 4 of the presentation
• Significant opportunity for value creation as further positive clinical data is generated; cashflow will likely follow a partnering transaction for paxalisib
Indicates the type of transaction they are working towards... cash up front and I really like the idea of partnering and not selling!!!!
- Forums
- ASX - By Stock
- KZA
- Ann: Kazia Investor Presentation
Ann: Kazia Investor Presentation, page-26
Featured News
Add KZA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online